Introducing a time out consultation with the general practitioner between diagnosis and start of colorectal cancer treatment: Patient‐reported outcomes

Wieldraaijer, Thijs; Meij, Marike de; Zwaard, Sophie; Weert, Henk van; Wind, Jan

doi:10.1111/ecc.13141

Cited by 20 publications

(20 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…(17) In addition, previous studies show that cancer patients are more satisfied if the GP is informed about the diagnosis (11) and if there is a contact moment with the GP (a "time out consultation") before start of treatment. (12) Our findings also support and explain the potential positive effect on SDM of actively involving the GP between diagnosis and therapy choice, which was recently reported for palliatively treated cancer patients. (13)…”

Section: Comparison With Existing Literaturesupporting

confidence: 87%

“…GP support could be enabled to support SDM in the hospital, for instance, by actively offering a 'time-out consultation' with the GP with SDM tools. 12 , 13 , 18 , 19 In addition, cancer patient organisations could support GP involvement by empowering patients to discuss preferred topics with their GP.…”

Section: Discussionmentioning

confidence: 99%

“…(11) Wieldraaijer et al showed that a consultation with the GP between diagnosis and start of treatment is beneficial for patient"s feelings of comfort and satisfaction. (12) We demonstrated earlier that a cancer related GP consultation before treatment decision may improve the SDM process of palliatively treated cancer patients according to patients, GPs and treating physicians. (13) A c c e p t e d M a n u s c r i p t -B J G P O p e n -b j g p o p e n 2 0 X 1 0 1 1 2 4…”

Section: Introductionmentioning

confidence: 90%

See 2 more Smart Citations

GP involvement after a cancer diagnosis; patients’ call to improve decision support

et al. 2020

View full text Add to dashboard Cite

Background Shared decision making (SDM) is considered important to realise personalised cancer care. Increased general practitioner (GP) involvement after a diagnosis is advocated to improve SDM. Aim To explore if cancer patients are in need of GP involvement in cancer care in general and in SDM, and whether GP involvement occurred. Design and Setting An online national survey distributed by the Dutch Federation of Cancer Patient Organisation (NFK) in May 2019. Methods The survey was sent to (former) cancer patients. Topics included GP involvement in cancer care in general and in SDM. Descriptive statistics and quotes were used. Results Among 4,763 (former) cancer patients, 59% (N=2,804) expressed a need for GP involvement in cancer care. Of these patients, 79% (N=2,193) experienced GP involvement. Regarding GP involvement in SDM, 82% of the patients (N=3,724) expressed that the GP should “listen to patient’s worries and considerations”, 69% (N=3,130) to “check patient’s understanding of information”, 66% (N=3,006) to “discuss patient’s priorities in life and the consequences of treatment options for these priorities”, and 67% (N=3,045) to “create awareness of the patient’s role in the decision making”. This happened in 47%, 17%, 15% and 10% of these patients, respectively. Conclusion The majority of (former) cancer patients expressed a need for active GP involvement in cancer care. GP support in the fundamental SDM steps is presently insufficient. Therefore, GPs should be made aware of these needs and enabled to support their cancer patients in SDM. Keywords Neoplasms; general practice; decision making, shared.

show abstract

Section: Comparison With Existing Literaturesupporting

confidence: 87%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 90%

See 1 more Smart Citation

GP involvement after a cancer diagnosis; patients’ call to improve decision support

et al. 2020

View full text Add to dashboard Cite

show abstract

“…A clear indication that our sample suffered from some form of selection bias were the remarkably high scores on the other questionnaires too. Two recent studies in Dutch cancer patients [38, 39] showed substantially lower SDM-Q-9 scores and higher decisional conflict scores. In addition, two recent studies in Dutch cancer patients [40] and Dutch cancer survivors [41] showed somewhat lower patients’ perceived self-efficacy compared to our sample.…”

Section: Discussionmentioning

confidence: 99%

Patient and physician shared decision making behaviors in oncology: Evidence on adequate measurement properties of the iSHARE questionnaires

Bomhof-Roordink

Stiggelbout

Gärtner

et al. 2021

Preprint

View full text Add to dashboard Cite

Objectives: We have developed two questionnaires to assess the shared decision making (SDM) process in oncology; the iSHAREpatient and iSHAREphysician. In this study, we aimed to determine: scores, construct validity, test-retest agreement (iSHAREpatient), and inter-rater (iSHAREpatient-iSHAREphysician) agreement. Methods: Physicians from seven Dutch hospitals recruited cancer patients, and completed the iSHAREphysician and SDM-Questionnaire-physician version. Their patients completed the: iSHAREpatient, 9-item SDM-Questionnaire, Decisional Conflict Scale, Combined Outcome Measure for Risk communication And treatment Decision making Effectiveness, and Perceived Efficacy in Patient-Physician Interactions. We formulated, respectively, one (iSHAREphysician) and 10 (iSHAREpatient) a priori hypotheses regarding correlations between the iSHARE questionnaires and questionnaires assessing related constructs. To assess test-retest agreement patients completed the iSHAREpatient again 1-2 weeks later. Results: In total, 151 treatment decision making processes with unique patients were rated. Dimension and total iSHARE scores were high both in patients and physicians. The hypothesis on the iSHAREphysician and 9/10 hypotheses on the iSHAREpatient were confirmed. Test-retest and inter-rater agreement were >.60 for most items. Conclusions: The iSHARE questionnaires show high scores, have good construct validity, substantial test-retest agreement, and moderate inter-rater agreement. Practice implications: Results from the iSHARE questionnaires can inform both physician- and patient-directed efforts to improve SDM in clinical practice.

show abstract

“…At present, radical resection of CRC is the main treatment method for CRC. With the gradual development of radical surgical techniques for CRC, the resection rate and radical treatment rate of CRC increased signi cantly, and the morality rate of patients also decreased signi cantly [1,2]. However, the 5-year survival rate of CRC is still low owing to the metastasis and recurrence after operation.…”

Section: Introductionmentioning

confidence: 99%

Intrathecal or Extracapuslar Lymph Nodes Dissection For Patients With Rectal and Sigmoid Colon Cancer？

Shao

Gong

et al. 2021

Preprint

View full text Add to dashboard Cite

Aim: To investigate that whether intrathecal lymph nodes dissection is superior to extracapsular lymph nodes dissection for patients with rectal and sigmoid colon cancer.Methods: We performed a retrospective clinical study between August, 2017 and October, 2019 at the department of general surgery, the affiliated hospital of Nanjing University Medical School. According to the ways of lymph nodes dissection, these patients were divided into extracapuslar group and intrathecal group. We then compared the curative effect and safety between the two groups.Results: A total of 211 patients were recruited in this retrospective study and assigned as follows: 62 cases to the intrathecal group and 149 patients to extracapuslar group. There were no statistic differences in the total number of lymph nodes, number of positive lymph nodes, and nodal staging between the two groups. However, the amount of bleeding in intrathecal group was significantly higher than that in extracapuslar group (p=0.000) and the operation time in intrathecal group was also significantly longer than that in extracapuslar group (p=0.000).Conclusion: Dissecting lymph nodes by extracapuslar dissection is preferred in radical resection of patients with rectal and sigmoid colon cancer. Statement: This paper compared the curative effect and safety between intrathecal and extracapsular lymph nodes dissection for patients with rectal and sigmoid colon cancer. This topic has never been reported in the literature and has great clinical significance.

show abstract

Introducing a time out consultation with the general practitioner between diagnosis and start of colorectal cancer treatment: Patient‐reported outcomes

Cited by 20 publications

References 20 publications

GP involvement after a cancer diagnosis; patients’ call to improve decision support

GP involvement after a cancer diagnosis; patients’ call to improve decision support

Patient and physician shared decision making behaviors in oncology: Evidence on adequate measurement properties of the iSHARE questionnaires

Intrathecal or Extracapuslar Lymph Nodes Dissection For Patients With Rectal and Sigmoid Colon Cancer？

Contact Info

Product

Resources

About